当前位置: 首页 > 期刊 > 《世界华人消化杂志》 > 2003年第8期
编号:10691895
乙型和丙型肝炎病毒蛋白对于细胞周期素A的调节研究
http://www.100md.com 2003年8月15日 《世界华人消化杂志》 2003年第8期
     成军,刘妍, 王琳,钟彦伟, 王刚,中国人民解放军第302医院传染病研究所基因治疗研究中心, 全军病毒性肝炎防治研究重点实验室 北京市 100039

    国家自然科学基金资助项目,No.C39970674, No. C03011402

    项目负责人:成军, 100039, 北京市西四环中路100号,中国人民解放军第302医院传染病研究所基因治疗研究中心,全军病毒性肝炎防治研究重点实验室. cj@genetherapy.com.cn

    电话:010-66933391 传真:010-63801283

    收稿日期:2003-03-08 接受日期:2003-04-16
, http://www.100md.com
    成军,刘妍, 王琳,钟彦伟, 王刚.乙型和丙型肝炎病毒蛋白对于细胞周期素A的调节研究.世界华人消化杂志 2003;11(8):1250-1254

    Wang J, Chenivesse X, Henglein B, Brechot C. Hepatitis B virusintegration in a cyclin A gene in a hepatocellular

    carcinoma. Nature 1990;343:555-557

    2 Wang J, Zindy F, Chenivesse X, Lamas E, Henglein B, Brechot C.Modification of cyclin A expression by hepatitis B virus

    DNA integration in a hepatocellularcarcinoma. Oncogene 1992;7:1653-1656
, 百拇医药
    3 De Mitri MS, Pisi E, Brechot C, Paterlini P. Low frequency ofallelic loss in the cyclin A gene in human

    hepatocellular carcinomas: a study based onPCR. Liver 1993;13:259-261

    4 Zhang Y, Peng Z,Qiu G, Wang Z, Gu W. Overexpression of cyclin A in hepatocellularcarcinoma and its relationship

    with HBx gene integration. ZhonghuaZhongliu Zazhi 2002;24:353-355

, 百拇医药     5 Masaki T, Shiratori Y, Rengifo W, Igarashi K, Matsumoto K, NishiokaM, Hatanaka Y, Omata M. Hepatocellular

    carcinoma cell cycle: study of Long-Evanscinnamon rats. Hepatology 2000;32:711-720

    6 Werling K, Szepesi A, Szentirmay Z, Schaff Z, Tulassay Z, Szalay F.Effect of hepatitis C virus on hepatocyte

    proliferation and DNA ploidy in patientswith chronic hepatitis C. Z Gastroenterol 200l;38:553-558
, 百拇医药
    7 Chao Y, Shih YL, Chiu JH, Chau GY, Lui WY, Yang WK, Lee SD, HuangTS. Overexpression of cyclin A but not Skp

    2 correlates with the tumor relapse ofhuman hepatocellular carcinoma. Cancer Res 1998;58:985-990

    8 Paterlini P, Flejou JF, De Mitri MS, Pisi E, Franco D, Brechot C.Structure and expression of the cyclin A gene in

    human primary liver cancer. Correlationwith flow cytometric parameters. J Hepatol 1995;23:47-52
, http://www.100md.com
    9 Romeo R, Pol S, Demeret C, Thiers V, Kremsdorf D, Cuillerier E,Berthelot P, Brechot C. Evidence of non-A, non-B,non-C infection in chronic hepatitis bypolymerase chain reaction testing for hepatitis B and C viruses. J Hepatol

    1995;22:125-129

    10 Faivre J, Frank-Vaillant M, Poulhe R, Mouly H, Jessus C, Brechot C,Sobczak-Thepot J. Centrosome

    overduplication, increased ploidy andtransformation in cells expressing endoplasmic reticulum-associated
, http://www.100md.com
    cyclin A2. Oncogene 2002;21:1493-1500

    11 Tarn C, Lee S, Hu Y, Ashendel C, Andrisani OM. Hepatitis B virus Xprotein differentially activates RAS-RAF-MAPK and

    JNK pathways in X-transforming versusnon-transforming AML12 hepatocytes. J Biol Chem 2001;276:34671-34680

    12 Bouchard M, Giannakopoulos S, Wang EH, Tanese N, Schneider RJ.Hepatitis B virus HBx protein activation of
, 百拇医药
    cyclin A-cyclin-dependent kinase 2complexes and G1 transit via a Src kinase pathway. J Virol 2001;75:4247-4257

    13 Berasain C, Patil D, Perara E, Huang SM, Mouly H, Brechot C.Oncogenic activation of a human cyclin A2 targeted to

    the endoplasmic reticulum upon hepatitis Bvirus genome insertion. Oncogene 1998;16:1277-1288

    14 Haviv I, Matza Y, Shaul Y. pX, the HBV-encoded coactivator,suppresses the phenotypes of TBP and TAFII250
, 百拇医药
    mutants. Genes Dev 1998;12:1217-1226

    15 Wolowiec D, Ffrench M. Cyclins A and B: redundancy and specificity.Pathol Biol (Paris) 1993;41:547-553

    16 Strassburg CP, Alex B, Zindy F, Gerken G, Luttig B, Meyer zumBuschenfelde KH, Brechot C, Manns MP. Identification

    of cyclin A as a molecular target ofantinuclear antibodies (ANA) in hepatic and non-hepatic autoimmunediseases.
, http://www.100md.com
    J Hepatol 1996;25:859-866

    17 Blanc P, Etienne H, Daujat M, Fabre I, Zindy F, Domergue J, AstreC, Saint Aubert B, Michel H, Maurel P.

    Mitotic responsiveness of cultured adulthuman hepatocytes to epidermal growth factor, transforming growthfactor

    alpha, and human serum. Gastroenterology 1992;102:1340-1350

    18 Ilyin GP, Langouet S, Rissel M, Delcros JG, Guillouzo A,Guguen-Guillouzo C. Ribavirin inhibits protein synthesis and
, 百拇医药
    cell proliferation induced by mitogenicfactors in primary human and rat hepatocytes. Hepatology 1998;27:1687-1694

    19 Lee S, Tarn C, Wang WH, Chen S, Hullinger RL, Andrisani OM.Hepatitis B virus X protein differentially regulates cell

    cycle progression in X-transforming versusnontransforming hepatocyte (AML12) cell lines. J Biol Chem

    2002;277:8730-8740

    20 Ozturk M. Genetic aspects of hepatocellular carcinogenesis. SeminLiver Dis 1999;19:235-242
, http://www.100md.com
    21 D'Errico A, Fiorentino M, Ponzetto A, Daikuhara Y, Tsubouchi H,Brechot C, Scoazec JY, Grigioni WF. Liver

    hepatocyte growth factor does not alwayscorrelate with hepatocellular proliferation in human liver lesions:

    its specific receptor c-met does.Hepatology 1996;24:60-64

    22 Brechot C. Oncogenic activation of cyclin A. Curr Opin Genet Dev 1993;3:11-18

    23 Wolowiec D, Ffrench M. Mitotic cyclins-new possibilities forexamining mechanisms of neoplasm growth. Postepy Hig
, 百拇医药
    Med Dosw 1993;47:183-191

    24 Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. Cyclin A isrequired at two points in the human cell cycle.

    EMBO J 1992;11:961-971

    25 Blanquet V, Wang JA, Chenivesse X, Henglein B, Garreau F, BrechotC, Turleau C. Assignment of a human cyclin

    A gene to 4q26-q27. Genomics 1990;8:595-597, 百拇医药( 成 军, 刘 妍, 王 琳, 钟彦伟, 王 刚)
  • 查看PDF全文